M28 Capital Management LP Curis Inc Transaction History

M28 Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.57 - $0.99 $865,179 - $1.5 Million	1,517,858 Added 33.86%	6,000,000 $4.98 Million
Q3 2022 Nov 10, 2022	BUY	$0.74 - $15.01 $176,748 - $3.59 Million	238,849 Added 5.63%	4,482,142 $3.14 Million
Q1 2022 May 13, 2022	BUY	$2.31 - $5.13 $3.78 Million - $8.38 Million	1,634,442 Added 62.65%	4,243,293 $10.1 Million
Q4 2021 Feb 11, 2022	BUY	$4.45 - $8.09 $11.6 Million - $21.1 Million	2,608,851 New	2,608,851 $12.4 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of M28 Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on M28 Capital Management LP with notifications on news.